Yinghong Wang

15.8k total citations
271 papers, 4.4k citations indexed

About

Yinghong Wang is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Yinghong Wang has authored 271 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 150 papers in Oncology, 92 papers in Epidemiology and 35 papers in Surgery. Recurrent topics in Yinghong Wang's work include Cancer Immunotherapy and Biomarkers (109 papers), Microscopic Colitis (68 papers) and Colorectal Cancer Treatments and Studies (62 papers). Yinghong Wang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (109 papers), Microscopic Colitis (68 papers) and Colorectal Cancer Treatments and Studies (62 papers). Yinghong Wang collaborates with scholars based in United States, China and Taiwan. Yinghong Wang's co-authors include Hamzah Abu‐Sbeih, Faisal S. Ali, Wei Qiao, Wenyi Luo, Anusha Shirwaikar Thomas, Gottumukkala S. Raju, David M. Richards, Mehmet Altan, Michael Dougan and Li Ding and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Yinghong Wang

236 papers receiving 4.3k citations

Peers

Yinghong Wang

ONCOL

EPIDE

IMMUN

PRM

Antonella Petrillo Italy

Zheng Wang China

Xiaolan Zhang China

Sze Chuen Cesar Wong Hong Kong

De‐Shen Wang China

Jiaqi Shi China

Jian Jiang China

Zhi Li China

Hao Tang China

Lei Liang China

Antonella Petrillo Italy

Yinghong Wang

1.8k ×0.7

ONCOL

507 ×0.6

EPIDE

423 ×0.6

290 ×0.4

IMMUN

1.1k ×2.2

PRM

Citations per year, relative to Yinghong Wang Yinghong Wang (= 1×) peers Antonella Petrillo

Countries citing papers authored by Yinghong Wang

Since Specialization

Citations

This map shows the geographic impact of Yinghong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinghong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinghong Wang more than expected).

Fields of papers citing papers by Yinghong Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinghong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinghong Wang. The network helps show where Yinghong Wang may publish in the future.

Co-authorship network of co-authors of Yinghong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yinghong Wang. A scholar is included among the top collaborators of Yinghong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinghong Wang. Yinghong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shatila, Malek, et al.. (2025). Predictive Value of FDG Uptake on PET for Future Immune Checkpoint Inhibitor-Mediated Colitis: A Case Series. Journal of Clinical Medicine. 14(1). 256–256.

Cruz, Carolina Colli, et al.. (2025). Gastrointestinal toxicities associated with immune checkpoint inhibitors therapy: risks and management. Immunotherapy. 17(4). 293–303. 1 indexed citations

Shatila, Malek, et al.. (2024). Effect of fecal transplantation on patient reported outcomes after immune checkpoint inhibitor colitis.. Journal of Clinical Oncology. 42(16_suppl). 2517–2517. 3 indexed citations

Okhuysen, Pablo C., et al.. (2024). The impact of cancer-related diarrhea on changes in cancer therapy. Supportive Care in Cancer. 32(10). 668–668.

Thomas, Anusha Shirwaikar, Lu Yang, John A. Thompson, et al.. (2024). Immune Checkpoint Inhibitor–Induced Colitis. Gastroenterology. 168(1). 21–28. 1 indexed citations

Ratliff, Hunter N., Malek Shatila, Muhammad Ali Khan, et al.. (2023). The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events due to Immune Checkpoint Inhibitors: a Systematic Review. Journal of Cancer. 14(16). 2956–2963. 10 indexed citations

Badran, Yousef R., Fangwen Zou, Sienna Durbin, et al.. (2023). Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis. Journal for ImmunoTherapy of Cancer. 11(6). e007195–e007195. 17 indexed citations

Wang, Yinghong, Robert R. Jenq, Jennifer A. Wargo, & Stephanie S. Watowich. (2023). Microbiome influencers of checkpoint blockade–associated toxicity. The Journal of Experimental Medicine. 220(3). 21 indexed citations

Wang, Yinghong, Malek Shatila, Anusha Shirwaikar Thomas, et al.. (2023). Tu1734 RANDOMIZED CLINICAL TRIAL OF INFLIXIMAB VERSUS VEDOLIZUMAB FOR IMMUNE CHECKPOINT INHIBITOR RELATED COLITIS. Gastroenterology. 164(6). S–1101. 1 indexed citations

10.

Miller, Ethan, et al.. (2023). Tu1570 EXPLORING CLINICAL OUTCOMES IN IMMUNE CHECKPOINT INHIBITOR-MEDIATED HEPATOBILIARY TOXICITY MANAGED WITH ORAL BUDESONIDE: AN INTRODUCTION TO NOVEL STRATEGIES. Gastroenterology. 164(6). S–1418. 1 indexed citations

11.

Wei, Dongguang, et al.. (2022). Severe Inflammatory Colitis Related to Encorafenib and Binimetinib following Immune Checkpoint Inhibitor Therapy. Case Reports in Gastroenterology. 16(2). 388–393. 2 indexed citations

12.

Liu, Cynthia, Dongfeng Tan, Mehmet Altan, et al.. (2022). Characteristics and outcomes of cancer patients with pre-existing microscopic colitis after exposure to PD-1 and PD-L1 inhibitors. Journal of Cancer Research and Clinical Oncology. 149(8). 5429–5436. 2 indexed citations

13.

Abu‐Sbeih, Hamzah, Niharika Mallepally, Tenglong Tang, et al.. (2020). Gastrointestinal toxic effects in patients with cancer receiving platinum-based therapy. Journal of Cancer. 11(11). 3144–3150. 14 indexed citations

14.

Abu‐Sbeih, Hamzah, Tenglong Tang, Mehmet Altan, et al.. (2019). Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis. Journal for ImmunoTherapy of Cancer. 7(1). 242–242. 63 indexed citations

15.

Wang, Yinghong, et al.. (2011). Power Saving Mechanism with Optimal Sleep Control in Wireless Sensor Networks. Journal of Applied Science and Engineering. 14(3). 235–243. 6 indexed citations

16.

Wang, Yinghong, et al.. (2008). HPLC‐MS及びHPLC‐1H‐NMRによるSmilax glabra(ドブクリョウ(土茯苓))のジヒドロフラボノールグリコシド異性体の同定. China Journal of Chinese Materia Medica. 33(11). 1281–1284. 1 indexed citations

17.

Wang, Yinghong, et al.. (2006). Construction and characterization of recombinant fowlpox virus co-expressing F and HN genes of newcastle disease virus and gB gene of infectious larygnotracheitis virus. Chinese journal of biotechnology/Shengwu gongcheng xuebao. 22(6). 931–938. 3 indexed citations

18.

Wang, Yinghong, et al.. (2005). Soil respiration of a coniferous and broad-leaved mixed forest in Dinghushan Mountain, Guangdong Province. Beijing Linye Daxue xuebao. 27(4). 23–27. 11 indexed citations

19.

Wang, Yinghong, et al.. (2002). Mobile Agents over E-business.. Computers and Their Applications. 483–486.

20.

Wang, Yinghong, et al.. (2002). A Novel Agent based E-Marketplace Mechanism over E-Business.. 30–35. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact